Schlote T
Ophthalmology, Tagesklinik Ambimed, Klingentalstrasse 9, Basel, Switzerland.
Klin Monbl Augenheilkd. 2013 Feb;230(2):120-6. doi: 10.1055/s-0032-1327784. Epub 2013 Feb 21.
Beta-blockers are among the most important groups of drugs for glaucoma therapy. The advantages of beta-blockers are a good efficacy in primary and secondary types of glaucoma, different dosages, clinical experiences over decades, easy use in combination with all other glaucoma drugs, and low costs. Timolol is the most frequently used drug in fixed glaucoma medications. In comparison with other glaucoma drugs, beta-blockers have the most severe systemic side effects and may interact with other systemic medication.
β受体阻滞剂是青光眼治疗中最重要的药物类别之一。β受体阻滞剂的优点包括对原发性和继发性青光眼疗效良好、有不同剂量、数十年的临床经验、易于与所有其他青光眼药物联合使用以及成本低廉。噻吗洛尔是固定复方青光眼药物中最常用的药物。与其他青光眼药物相比,β受体阻滞剂具有最严重的全身副作用,并且可能与其他全身用药发生相互作用。